Market DemandThere is robust demand in the US driven by the need for advanced medical equipment and procedures, indicating a healthy hospital capital expenditure cycle.
Product DevelopmentA robust product pipeline to say the least — Including a 'full refresh' of the Ultrasound portfolio with new solutions in cardiovascular, women’s health, and AI.
Revenue GrowthGEHC raised its full-year organic revenue growth guidance to around 3%, indicating confidence in its performance despite moderating expectations in China.